Law firms and lobby shops in Washington, D.C., are seeing an influx of business from health care and pharmaceutical clients, leading to a series of new hires and revolving door spins as firms bulk up their health care policy groups.

Appropriation bills, Food and Drug Administration discussions over so-called user fee agreements and legislation on health care preparedness are all driving business now.